Investor Relations section

Welcome to Ark Therapeutics Investor Relations Centre.

Here we aim to provide current and potential investors with access to information, including our regulatory announcements, broker forecast information and an archive of our current/previous company reports, along with other financial related materials and tools.

Latest News



Data provided by Hemscott Group Limited.
Disclaimer
Share Price
3.52p

Change: 0.14p

At: 28/01/2012 10:07:28

Annual Reports Keep up to date
Keep up-to-date with product developments, investor relations information and news with our email updates. Register here to receive our email alerts.